References
-
Raharja, A., Mahil, S. K. & Barker, J. N. Psoriasis: a brief overview. Clin. Med. 21, 170–173 (2021).
-
Hay, S. I. et al. Global, regional, and National disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390, 1260–1344 (2017).
-
Ganzetti, G. et al. Salivary interleukin-1beta: oral inflammatory biomarker in patients with psoriasis. J. Int. Med. Res. 44, 10–14 (2016).
-
Deng, Y., Chang, C. & Lu, Q. The inflammatory response in psoriasis: a comprehensive review. Clin. Rev. Allergy Immunol. 50, 377–389 (2016).
-
Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y. & Blauvelt, A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 130, 1373–1383 (2010).
-
Verghese, B., Bhatnagar, S., Tanwar, R. & Bhattacharjee, J. Serum cytokine profile in psoriasis-a case-control study in a tertiary care hospital from Northern India. Indian J. Clin. Biochem. 26, 373–377 (2011).
-
Cardoso, P. R. et al. Clinical and cytokine profile evaluation in Northeast Brazilian psoriasis plaque-type patients. Eur. Cytokine Netw. 27, 1–5 (2016).
-
Liu, R., Yang, Y., Yan, X. & Zhang, K. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions. Eur. J. Dermatol. 23, 600–607 (2013).
-
Guenova, E. et al. IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc. Natl. Acad. Sci. U. S. A. 112, 2163–2168 (2015).
-
Onderdijk, A. J. et al. IL-4 downregulates IL-1beta and IL-6 and induces GATA3 in psoriatic epidermal cells: route of action of a Th2 cytokine. J. Immunol. 195, 1744–1752 (2015).
-
Samarasekera, E., Sawyer, L., Parnham, J. & Smith, C. H. Assessment and management of psoriasis: summary of NICE guidance. BMJ 345 (2012).
-
Ling, T. C. et al. British association of dermatologists and British photodermatology group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015. Br. J. Dermatol. 174, 24–55 (2016).
-
Mahil, S. K. et al. BADBIR study group and the PSORT consortium: psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British association of dermatologists biologics and immunomodulators Register, BADBIR). Br. J. Dermatol. 182, 1158–1166 (2020).
-
Cheng, J. et al. Bioactive compounds and health benefits of pomegranate: an updated narrative review. Food Biosci. 53, 102629 (2023).
-
Feldman, S. R. & Krueger, G. Psoriasis assessment tools in clinical trials. Ann. Rheum. Dis. 64, ii65–ii68 (2005).
-
Elkhawaga, O. Y., Ellety, M. M., Mofty, S. O., Ghanem, M. S. & Mohamed, A. O. Review of natural compounds for potential psoriasis treatment. Inflammopharmacology 31, 1183–1198 (2023).
-
Singh, K. K. & Tripathy, S. Natural treatment alternative for psoriasis: A review on herbal resources. J. Appl. Pharm. Sci. 4, 114–121 (2014).
-
Brown, A. C. et al. Medical nutrition therapy as a potential complementary treatment for psoriasis-five case reports. Altern. Med. Rev. 9, 297–307 (2004).
-
Mo, Y. et al. Pomegranate Peel as a source of bioactive compounds: A mini review on their physiological functions. Front. Nutr. 9, 887113 (2022).
-
Wu, Y., Zhu, C. P., Zhang, Y., Li, Y. & Sun, J. R. Immunomodulatory and antioxidant effects of pomegranate Peel polysaccharides on immunosuppressed mice. Int. J. Biol. Macromol. 137, 504–511 (2019).
-
Zhai, X. et al. Chemical characteristics, antioxidant capacities and hepatoprotection of polysaccharides from pomegranate Peel. Carbohydr. Polym. 202, 461–469 (2018a).
-
Zhai, X. et al. Optimization for pectinase-assisted extraction of polysaccharides from pomegranate Peel with chemical composition and antioxidant activity. Int. J. Biol. Macromol. 202, 461–469 (2018).
-
Panichayupakaranant, P., Itsuriya, A. & Sirikatitham, A. Preparation method and stability of ellagic acid-rich pomegranate fruit Peel extract. Pharm. Biol. 48, 201–205 (2010).
-
Ismail, T., Sestili, P. & Akhtar, S. Pomegranate Peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J. Ethnopharmacol. 143, 397–405 (2012).
-
Tamborlin, L. et al. Characterization of pomegranate Peel extracts obtained using different solvents and their effects on cell cycle and apoptosis in leukemia cells. Food Sci. Nutr. 8, 5483–5496 (2020).
-
Kaderides, K. & Goula, A. M. Encapsulation of pomegranate Peel extract with a new carrier material from orange juice by-products. J. Food Eng. 253, 1–13 (2019).
-
Mohammadi, M., Boghrati, Z., Emami, S. A. & Akaberi, M. Pomegranate: A review of the heavenly healer’s past, present, and future. Iran. J. Basic. Med. Sci. 26, 1245 (2023).
-
Siddiqui, S. A., Singh, S. & Nayik, G. A. Bioactive compounds from pomegranate peels-Biological properties, structure-function relationships, health benefits, and food applications-A comprehensive review. J. Funct. Foods. 116, 106132 (2024).
-
Enaru, B., Drețcanu, G., Pop, T. D., Stǎnilǎ, A. & Diaconeasa, Z. Anthocyanins: factors affecting their stability and degradation. Antioxidants 10, 1967 (2021).
-
Elbouzidi, A. et al. Biochemical insights into specialized plant metabolites: advancing cosmeceutical applications for skin benefits. J. Agric. Food Res. 19, 101651 (2025).
-
Morsy, M. K., Mekawi, E. & Elsabagh, R. Impact of pomegranate Peel nanoparticles on quality attributes of meatballs during refrigerated storage. LWT Food Sci. Technol. 89, 489–495 (2017).
-
Salem, Y. et al. Grape seed phenolic extracts encapsulation in polymeric nanoparticles: characterization and in vitro evaluation against skin melanoma. J. Drug Deliv Sci. Technol. 100, 106094 (2024).
-
Association of Official Analytical Chemists. Official methods of analysis. J. AOAC Int. 83, 1–15 (2000).
-
Balamurugan, V., Fatima, M. A. S. & Velurajan, S. A guide to phytochemical analysis. IJARIIE 5, 236–245 (2019).
-
Sweidan, N., Rayyan, A., Mahmoud, W. & Ali, I. Phytochemical analysis, antioxidant, and antimicrobial activities of Jordanian pomegranate peels. PLoS One. 18, e0295129 (2023).
-
Li, Y. et al. Evaluation of antioxidant properties of pomegranate Peel extract in comparison with pomegranate pulp extract. Food Chem. 96, 254–260 (2006).
-
Djeridane, A. et al. Antioxidant activity of some Algerian medicinal plant extracts containing phenolic compounds. Food Chem. 97, 654–660 (2006).
-
Mostafa, H., Airouyuwa, J. O. & Maqsood, S. A novel strategy for producing nanoparticles from date seeds and enhancing their phenolic content and antioxidant properties using ultrasound-assisted extraction: A multivariate-based optimization study. Ultrason. Sonochem. 87, 106017 (2022).
-
Weng, J., Tong, H. H. Y. & Chow, S. F. In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method. Pharmaceutics 12, 732 (2020).
-
Salim, A. et al. Antimicrobial and antibiofilm activities of pomegranate Peel phenolic compounds: varietal screening through a multivariate approach. J. Bioresour Bioprod. 8, 146–161 (2023).
-
Horváth, S. et al. Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice. Sci. Rep. 9, 3685 (2019).
-
Afaq, F., Saleem, M., Krueger, C. G., Reed, J. D. & Mukhtar, H. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer. 113, 423–433 (2005).
-
Lansky, E. P. & Newman, R. A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol. 109, 177–206 (2007).
-
Teniente, S. L. et al. Anticancer effect of pomegranate Peel polyphenols against cervical cancer. Antioxidants 12, 127 (2023).
-
Ferrentino, G., Asaduzzaman, M. & Scampicchio, M. M. Current technologies and new insights for the recovery of high valuable compounds from fruits by-products. Crit. Rev. Food Sci. Nutr. 58, 386–404 (2018).
-
Wu, S. & Tian, L. Diverse phytochemicals and bioactivities in the ancient fruit and modern functional food pomegranate (Punica granatum). Molecules 22, 1606 (2017).
-
Kahramanoglu, I. Trends in pomegranate sector: Production, postharvest handling and marketing. Int. J. Agric. Life Sci. 3, 239–246 (2019).
-
Mastrogiovanni, F. et al. Anti-inflammatory effects of pomegranate Peel extracts on in vitro human intestinal Caco-2 cells and ex vivo Porcine colonic tissue explants. Nutrients 11, 548 (2019).
-
Ko, K., Dadmohammadi, Y. & Abbaspourrad, A. Nutritional and bioactive components of pomegranate waste used in food and cosmetic applications: a review. Foods 10, 657 (2021).
-
Mudshinge, S. R., Deore, A. B., Patil, S. & Bhalgat, C. M. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm. J. 19, 129–141 (2011).
-
Naji-Tabasi, S., Razavi, S. M. A. & Mehditabar, H. Fabrication of Basil seed gum nanoparticles as a novel oral delivery system of glutathione. Carbohydr. Polym. 157, 1703–1713 (2017).
-
Xiong, K. et al. Construction of food-grade pH-sensitive nanoparticles for delivering functional food ingredients. Trends Food Sci. Technol. 96, 102–113 (2020).
-
Zayed, A., Badawy, M. T. & Farag, M. A. Valorization and extraction optimization of citrus seeds for food and functional food applications. Food Chem. 355 (2021).
-
Guo, Y. et al. Petroselinic acid from apiaceae family plants ameliorates autoimmune disorders through suppressing cytosolic-nucleic-acid-mediated type i interferon signaling. Biomolecules 15, 329 (2025).
-
Gunasekaran, T., Haile, T., Nigusse, T. & Dhanaraju, M. D. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac. J. Trop. Biomed. 4, S1–S7 (2014).
-
Barichello, J. M., Morishita, M., Takayama, K. & Nagai, T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 25, 471–476 (1999).
-
van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836–5845 (2009).
-
El Malki, K. et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J. Invest. Dermatol. 133, 441–451 (2013).
-
Nadeem, A. et al. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacol. Res. 99, 248–257 (2015).
-
Yu, Y. Q., Yang, X., Wu, X. F. & Fan, Y. B. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front. Bioeng. Biotechnol. 9, 646554 (2021).
-
Zheng, B. & McClements, D. J. Formulation of more efficacious Curcumin delivery systems using colloid science: enhanced solubility, stability, and bioavailability. Molecules 25, 279 (2020).
-
Yin, X. et al. Chemical stability of ascorbic acid integrated into commercial products: a review on bioactivity and delivery technology. Antioxidants 11, 153 (2022).
